Drug metabolism and pancreatic cancer

John Paul E. Flores, Robert B. Diasio, Muhammad Wasif Saif

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient’s individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality.

Original languageEnglish (US)
Pages (from-to)54-61
Number of pages8
JournalAnnals of Gastroenterology
Issue number1
StatePublished - 2017


  • Chemotherapy
  • Genomic profile
  • Genomics
  • Molecular pancreatic pathogenesis
  • Pancreatic cancer pharmacogenomics
  • Pancreatic exocrine cancer
  • Targeted therapy

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Drug metabolism and pancreatic cancer'. Together they form a unique fingerprint.

Cite this